Return to Transcripts main page

CNN Live Today

Rice Will Testify Under Oath, Publicly; 'Daily Dose'

Aired March 30, 2004 - 11:30   ET

THIS IS A RUSH TRANSCRIPT. THIS COPY MAY NOT BE IN ITS FINAL FORM AND MAY BE UPDATED.

THIS IS A RUSH TRANSCRIPT. THIS COPY MAY NOT BE IN ITS FINAL FORM AND MAY BE UPDATED.


DARYN KAGAN, CNN ANCHOR: Want to get back to our lead story, the breaking story coming out of the White House. The White House reversing position, offering up two things. One, National Security Adviser Condoleezza Rice, they say, will offer to testify in public under oath before the 9/11 Commission.
Also, the president and vice president will answer questions privately for all ten members of the commission, not just the chair and the vice chair, as was for the previous agreement. That will take place privately and not under oath, as we understand it at this time.

Let's bring in Michael Elliott. He's with "TIME" magazine, the editor at large, to talk about this developing news. Michael, good morning, thanks for being with us.

MICHAEL ELLIOTT, "TIME", EDITOR AT LARGE: Morning to you, Daryn.

KAGAN: Are you surprised at the reversal of position from the White House?

ELLIOTT: No, I'm not surprised because I think one of the first rules of politics is that when you're in a hole, you stop digging. And the administration had got itself into a terrific hole on the discussion of Dr. Rice's testimony. It had put itself into a completely untenable position where Republican members of the commission were saying that this was a major political mistake.

So sooner or later it was inevitable, it seemed to me, that the administration would back down. And what do you know? They have.

KAGAN: And as this is developing, there is an agreement, the White House asking for an agreement that this will not set a precedent, that this present commission will not ask for any other aides or members of the White House to testify.

Also, I think interestingly, saying never in the future. And I don't quite understand how this commission can make a promise for commissions at the future and future administrations.

ELLIOTT: You're reading the document like a lawyer, Daryn.

KAGAN: Which I'm not.

ELLIOTT: I think you're absolutely right. One other condition that is -- that is made explicit, incidentally, that I don't think has really been really focused on, is this is a one time deal with Dr. Rice. The letter says that they will not be able -- the commission will be able to do this sort of investigation with any other White House officials, including Dr. Rice. So the implication of that is this is a one time deal.

KAGAN: So get your questions in now.

ELLIOTT: Get your questions in now, exactly.

KAGAN: Whenever that now might be. We haven't been able to learn yet when this would exactly take place.

ELLIOTT: No, my guess it would be some time in April. But that's pure speculation on my part.

KAGAN: What about this other part, that the president and vice president agreeing to answer questions privately and not under oath but before all ten members of the commission?

ELLIOTT: Well That is an advance, as you said in your introduction, Daryn, from what one had assumed to be the case a while ago. And it seems as if they just talked to the commission -- I'm sorry, to the chairman and the deputy chairman. Now they'll talk to all ten members of the commission. There will be one commission staff member present who will take notes.

So I hope they've got good shorthand or something like that.

KAGAN: How does the president -- how does the White House spin this now, being so adamant up to this point, saying then this is just wrong, this is executive privilege, this is a matter of principle. How do you spin it?

ELLIOTT: We'll have to see what they say. I suppose they'll say -- as the general counsel to the White House says in his letter this is an extraordinary situation, that the 9/11 Commission has an extraordinarily important task, and, hence, that it was worth waiving executive privilege.

But this is in a small way, rather a significant morning because this is not an administration that likes admitting defeat, that likes going back on something that is has staked its position on. And doesn't like being browbeaten into doing something that it didn't want to do.

So this is a genuine -- let's put this on the record. This is a genuine case of the administration being forced by positions adopted by the commission, and for that matter, by the public, to reverse itself. That doesn't happen very off with this administration.

KAGAN: Which is why we are covering the story. Michael Elliott, "TIME" magazine, thank you.

ELLIOTT: Thank you, Daryn.

KAGAN: Another issue out there -- besides the war on terror, another big issue out there, rising gas prices. Both presidential candidates trying to make that a campaign issue. Our Candy Crowley has that and a lot more in our "Voter Alert: America Votes." Good morning, Candy.

CANDY CROWLEY, CNN SENIOR POLITICAL CORRESPONDENT: Good morning, Daryn. You're right, both presidential campaigns are trying to find some political mileage out of high gas prices. The average cost of self-serve regular unleaded is now at a record-setting $1.77 a gallon.

The Bush campaign is rolling out a new ad attacking John Kerry on the issue of gasoline taxes.

(BEGIN VIDEO CLIP)

AD ANNOUNCER: Some people have wacky ideas like taxing gasoline more so people drive less. That's John Kerry. He support a 50 cent a gallon gas tax. If Kerry's gas tax increase were law, the average family would pay $657 more a year.

(END VIDEO CLIP)

CROWLEY: John Kerry is not taking the criticism lightly. His aides blast the new Bush ad as shamelessly misleading. Late yesterday in San Francisco, Kerry linked higher gas prices with job losses under President Bush.

(BEGIN VIDEO CLIP)

SEN. JOHN KERRY (D-MA), PRESIDENTIAL CANDIDATE: But you have to give this administration credit because they clearly understand the connection between gas prices and the economy. Because their approach is -- to the solution to these high gas prices is just to make sure that nobody has a job to drive to.

(END VIDEO CLIP)

CROWLEY: Just how bad are gas prices really? It is the latest Lundberg Survey that shows the average price of a gallon of regular self-serve unleaded is at $1.77. But the actual price varies depending on where you live. Atlanta and Philadelphia drivers are paying less than those in Denver, Seattle, and especially Los Angeles.

And by the way the OPEC oil ministers meet tomorrow and are talking about cutting output, which would boost prices even more.

Senator Kerry stays in California today where he's expected to unveil his plan to rein in gas prices. Aides say Kerry will call for new pressure on OPEC countries and a new national fuel strategy. He will do all this during a speech in San Diego.

President Bush is headed for the battleground of Wisconsin at this hour. The economy will be issue one when he speaks with business and labor leaders in Appleton.

This afternoon on INSIDE POLITICS, Theresa Heinz Kerry and the Heinz Ketchup empire. Some nervous company executives are trying to get out the word they are not the same thing.

We'll also preview a technological innovation that may be coming soon to a computer near you: political pop up ads. Join me at 3:30 Eastern when I go INSIDE POLITICS. But right now, we want to go back to Daryn Kagan in Atlanta.

KAGAN: Candy, thank you for that.

Well these days it seems everyone is paying close attention to what the president is saying. Well almost everyone. Coming up, a Bush speech what? Watch the boy on the left side of your screen -- you got to see the whole video to believe it. Get ready for a chuckle.

Next, though, a blood breakthrough that could save lives when seconds count. There's a controversy, though, over how it's being tested. Would you want it used on you? Your "Daily Dose" of health news is next.

(COMMERCIAL BREAK)

KAGAN: Getting blood to trauma patients can mean the difference between life and death. A new blood substitute could increase chances for survival, but the way it's being tested is raising concern.

Medical Correspondent Dr. Sanjay Gupta has our "Daily Dose" of health news.

(BEGIN VIDEOTAPE)

DR. SANJAY GUPTA, CNN MEDICAL CORRESPONDENT (voice-over): After an accident or trauma, replacing lost blood immediately is critical. Organs in the body need the oxygen it carries for survival. Every second counts.

But it's often not practical for ambulances to carry blood. There are too many types, and it's perishable. Instead, paramedics buy time with saline, but that doesn't carry the oxygen the body is starved for.

So, not surprisingly, there is a lot of enthusiasm for a new blood substitute called polyheme. Created in a lab, it's made from expired blood. Scientists extract the oxygen-carrying substance hemoglobin from red blood cells to create the substitute. Polyheme's shelf life is over a year. It's compatible with every human blood type, saving the 30 to 60 minutes it normally takes to type in matched blood. It's also free of any harmful viruses.

But as with most seemingly perfect things, there is controversy. Turns out polyheme is being used in clinical trials in five cities. But most of the time, the patients who need it most are unconscious and can't give consent. Under a rarely used law, the FDA allows patient consent to be waived so scientists can develop desperately needed emergency treatment.

Lead investigator and trauma surgeon Ernest Moore says research in the field is the only way to prove that artificial blood can save lives. DR. ERNEST MOORE, CHIEF OF TRAUMA SURGERY, DENVER HEALTH MEDICAL CTR.: Unless we conduct research under these conditions, it'll never get done.

GUPTA: Patient advocates object, saying patients should always get their choice.

ARTHUR CAPLAN, MEDICAL ETHICIST: It's also not clear that the only way to try artificial blood is in this particular setting. You could have people volunteer, you could have restrictions only to people who are somewhat conscious or have a family member there and could give consent to this.

GUPTA: Dr. Moore says consent is already implied for IVs and breathing tubes. This should no different.

MOORE: Hopefully in patients who previously died because of blood loss we will now be able to save them.

GUPTA: The blood substitutes manufactures is handing out bracelets in the test cities to anyone who does not want it. But doctors involved in the study are hopeful a blood substitute will have broader use.

DR. MICHAEL PASQUALE, CHIEF OF DIV. OF TRAUMA, LEHIGH VALLEY HOSPITAL: The hope is that eventually you could potentially use this for any procedure where blood was required.

GUPTA: And potentially save many more lives.

Dr. Sanjay Gupta, CNN, Atlanta.

(END VIDEOTAPE)

KAGAN: You heard from the trauma surgeon, Ernest Moore, in that story. He's our guest now from Denver to talk more about this potentially life-saving blood substitute and the concerns over testing it.

Doctor Moore, good morning. Thank you for work us.

MOORE: Good morning.

KAGAN: If you could explain to us again or more specifically how this product work and why it can be, as you see it, life saving.

MOORE: Well, this product serves as actually a substitute for red cells. Their functioned to carry oxygen. So it's a temporary replacement when patients lose a massive amount of red cells.

Unfortunately, the current treatment, crystaloid, does not carry oxygen. Therefore, patients who have massive blood loss are an imminent threat for their life unless the oxygen-carrying capacity can be restored properly.

KAGAN: And so it sounds like a good thing. Why, though -- and you make this point in the piece -- but why do you believe it has to be tested in this way? Why can't it be tested in other ways?

MOORE: Well, first of all, it's important to understand it has been tested in other scenarios. At our institution, we have tested this product in patients with acute blood loss over the past 11 years. We have an experience over 150 patients. And, with the FDA, has closely scrutinized both its safety and efficacy, but it has never been tested in the scenario of the scene of the accident. That's why it's critical that this study be produced.

KAGAN: So as I understand it, in communities, as we heard in Sanjay's piece, in communities where this is being tested, you can go get a bracelet if you perhaps would be -- find yourself in an accident and you don't want this product used on you, if you have ethical or religious reasons that you wouldn't want a blood product used on you.

MOORE: That's correct.

KAGAN: And how far down the line, doctor, do you see if this product is completely approved and it works as well as you think it's going to, that this will be a normal part of treatment?

MOORE: Well, the study is planned for at least one year. But if the results are positive, this could completely revolutionize how we manage resuscitation of injured patients. We haven't made advances for over 35 years. This could represent the singular most important advance in the resuscitation of the injured patient in many of our lifetimes.

KAGAN: And you will be watching it from Denver. Dr. Ernest Moore, thanks for your time, doctor, appreciate it.

MOORE: Thank you.

KAGAN: Time for us to take a quick break. We'll be back, after this.

(COMMERCIAL BREAK)

(STOCK MARKET REPORT)

KAGAN: One more note, from the wise acres at "The David Letterman Show," whoever said that politics wasn't stimulating, even at a late hour, take a look at this.

(BEGIN VIDEO CLIP)

GEORGE W. BUSH, PRESIDENT OF THE UNTIED STATES: Need to maintain spending discipline in our nation's capital. I've had plans to protect small business owner and employees...

I actually did vote for the 87 billion...

(APPLAUSE)

... state house members, all the local officials. The high sheriff is with us today. (LAUGHTER)

... if you're worried about the quality of the education.

(LAUGHTER)

We stand for the fair treatment of faith-based groups, who will receive federal support for their work.

(LAUGHTER)

... will not happen on my watch.

(LAUGHTER)

(END VIDEO CLIP)

KAGAN: What is funnier, the kid or that everybody around him -- not a single person even reacts to those hijinks?

Had to share that giggle there.

We'll take a look at weather, coming up in just a bit.

(COMMERCIAL BREAK)

KAGAN: All right, had a good giggle before the break, that video from David Letterman. We're being told by the White House that the kid, as funny as he was, was edited into that video, which would explain why the people around him weren't really reacting. So that from the White House.

Speaking of what goes on the air, just as the FCC is cracking down on decency, syndicated shock jock Opie and Anthony reportedly will be back on the air in June. Infinity had reportedly yanked their show after an on-air stunt involving a man and woman who were supposed to be having sex in the St. Patrick's Cathedral. I remember that fun moment. Infinity didn't fire Opie and Anthony, rather they have remained under contract, drawing their paychecks. And now that contract is about to expire, paying the way for the duo's return.

All right then.

(WEATHER REPORT)

KAGAN: That's going to wrap it up for us. I'm Daryn Kagan. I will be right back here tomorrow morning.

TO ORDER A VIDEO OF THIS TRANSCRIPT, PLEASE CALL 800-CNN-NEWS OR USE OUR SECURE ONLINE ORDER FORM LOCATED AT www.fdch.com


Aired March 30, 2004 - 11:30   ET
THIS IS A RUSH TRANSCRIPT. THIS COPY MAY NOT BE IN ITS FINAL FORM AND MAY BE UPDATED.
DARYN KAGAN, CNN ANCHOR: Want to get back to our lead story, the breaking story coming out of the White House. The White House reversing position, offering up two things. One, National Security Adviser Condoleezza Rice, they say, will offer to testify in public under oath before the 9/11 Commission.
Also, the president and vice president will answer questions privately for all ten members of the commission, not just the chair and the vice chair, as was for the previous agreement. That will take place privately and not under oath, as we understand it at this time.

Let's bring in Michael Elliott. He's with "TIME" magazine, the editor at large, to talk about this developing news. Michael, good morning, thanks for being with us.

MICHAEL ELLIOTT, "TIME", EDITOR AT LARGE: Morning to you, Daryn.

KAGAN: Are you surprised at the reversal of position from the White House?

ELLIOTT: No, I'm not surprised because I think one of the first rules of politics is that when you're in a hole, you stop digging. And the administration had got itself into a terrific hole on the discussion of Dr. Rice's testimony. It had put itself into a completely untenable position where Republican members of the commission were saying that this was a major political mistake.

So sooner or later it was inevitable, it seemed to me, that the administration would back down. And what do you know? They have.

KAGAN: And as this is developing, there is an agreement, the White House asking for an agreement that this will not set a precedent, that this present commission will not ask for any other aides or members of the White House to testify.

Also, I think interestingly, saying never in the future. And I don't quite understand how this commission can make a promise for commissions at the future and future administrations.

ELLIOTT: You're reading the document like a lawyer, Daryn.

KAGAN: Which I'm not.

ELLIOTT: I think you're absolutely right. One other condition that is -- that is made explicit, incidentally, that I don't think has really been really focused on, is this is a one time deal with Dr. Rice. The letter says that they will not be able -- the commission will be able to do this sort of investigation with any other White House officials, including Dr. Rice. So the implication of that is this is a one time deal.

KAGAN: So get your questions in now.

ELLIOTT: Get your questions in now, exactly.

KAGAN: Whenever that now might be. We haven't been able to learn yet when this would exactly take place.

ELLIOTT: No, my guess it would be some time in April. But that's pure speculation on my part.

KAGAN: What about this other part, that the president and vice president agreeing to answer questions privately and not under oath but before all ten members of the commission?

ELLIOTT: Well That is an advance, as you said in your introduction, Daryn, from what one had assumed to be the case a while ago. And it seems as if they just talked to the commission -- I'm sorry, to the chairman and the deputy chairman. Now they'll talk to all ten members of the commission. There will be one commission staff member present who will take notes.

So I hope they've got good shorthand or something like that.

KAGAN: How does the president -- how does the White House spin this now, being so adamant up to this point, saying then this is just wrong, this is executive privilege, this is a matter of principle. How do you spin it?

ELLIOTT: We'll have to see what they say. I suppose they'll say -- as the general counsel to the White House says in his letter this is an extraordinary situation, that the 9/11 Commission has an extraordinarily important task, and, hence, that it was worth waiving executive privilege.

But this is in a small way, rather a significant morning because this is not an administration that likes admitting defeat, that likes going back on something that is has staked its position on. And doesn't like being browbeaten into doing something that it didn't want to do.

So this is a genuine -- let's put this on the record. This is a genuine case of the administration being forced by positions adopted by the commission, and for that matter, by the public, to reverse itself. That doesn't happen very off with this administration.

KAGAN: Which is why we are covering the story. Michael Elliott, "TIME" magazine, thank you.

ELLIOTT: Thank you, Daryn.

KAGAN: Another issue out there -- besides the war on terror, another big issue out there, rising gas prices. Both presidential candidates trying to make that a campaign issue. Our Candy Crowley has that and a lot more in our "Voter Alert: America Votes." Good morning, Candy.

CANDY CROWLEY, CNN SENIOR POLITICAL CORRESPONDENT: Good morning, Daryn. You're right, both presidential campaigns are trying to find some political mileage out of high gas prices. The average cost of self-serve regular unleaded is now at a record-setting $1.77 a gallon.

The Bush campaign is rolling out a new ad attacking John Kerry on the issue of gasoline taxes.

(BEGIN VIDEO CLIP)

AD ANNOUNCER: Some people have wacky ideas like taxing gasoline more so people drive less. That's John Kerry. He support a 50 cent a gallon gas tax. If Kerry's gas tax increase were law, the average family would pay $657 more a year.

(END VIDEO CLIP)

CROWLEY: John Kerry is not taking the criticism lightly. His aides blast the new Bush ad as shamelessly misleading. Late yesterday in San Francisco, Kerry linked higher gas prices with job losses under President Bush.

(BEGIN VIDEO CLIP)

SEN. JOHN KERRY (D-MA), PRESIDENTIAL CANDIDATE: But you have to give this administration credit because they clearly understand the connection between gas prices and the economy. Because their approach is -- to the solution to these high gas prices is just to make sure that nobody has a job to drive to.

(END VIDEO CLIP)

CROWLEY: Just how bad are gas prices really? It is the latest Lundberg Survey that shows the average price of a gallon of regular self-serve unleaded is at $1.77. But the actual price varies depending on where you live. Atlanta and Philadelphia drivers are paying less than those in Denver, Seattle, and especially Los Angeles.

And by the way the OPEC oil ministers meet tomorrow and are talking about cutting output, which would boost prices even more.

Senator Kerry stays in California today where he's expected to unveil his plan to rein in gas prices. Aides say Kerry will call for new pressure on OPEC countries and a new national fuel strategy. He will do all this during a speech in San Diego.

President Bush is headed for the battleground of Wisconsin at this hour. The economy will be issue one when he speaks with business and labor leaders in Appleton.

This afternoon on INSIDE POLITICS, Theresa Heinz Kerry and the Heinz Ketchup empire. Some nervous company executives are trying to get out the word they are not the same thing.

We'll also preview a technological innovation that may be coming soon to a computer near you: political pop up ads. Join me at 3:30 Eastern when I go INSIDE POLITICS. But right now, we want to go back to Daryn Kagan in Atlanta.

KAGAN: Candy, thank you for that.

Well these days it seems everyone is paying close attention to what the president is saying. Well almost everyone. Coming up, a Bush speech what? Watch the boy on the left side of your screen -- you got to see the whole video to believe it. Get ready for a chuckle.

Next, though, a blood breakthrough that could save lives when seconds count. There's a controversy, though, over how it's being tested. Would you want it used on you? Your "Daily Dose" of health news is next.

(COMMERCIAL BREAK)

KAGAN: Getting blood to trauma patients can mean the difference between life and death. A new blood substitute could increase chances for survival, but the way it's being tested is raising concern.

Medical Correspondent Dr. Sanjay Gupta has our "Daily Dose" of health news.

(BEGIN VIDEOTAPE)

DR. SANJAY GUPTA, CNN MEDICAL CORRESPONDENT (voice-over): After an accident or trauma, replacing lost blood immediately is critical. Organs in the body need the oxygen it carries for survival. Every second counts.

But it's often not practical for ambulances to carry blood. There are too many types, and it's perishable. Instead, paramedics buy time with saline, but that doesn't carry the oxygen the body is starved for.

So, not surprisingly, there is a lot of enthusiasm for a new blood substitute called polyheme. Created in a lab, it's made from expired blood. Scientists extract the oxygen-carrying substance hemoglobin from red blood cells to create the substitute. Polyheme's shelf life is over a year. It's compatible with every human blood type, saving the 30 to 60 minutes it normally takes to type in matched blood. It's also free of any harmful viruses.

But as with most seemingly perfect things, there is controversy. Turns out polyheme is being used in clinical trials in five cities. But most of the time, the patients who need it most are unconscious and can't give consent. Under a rarely used law, the FDA allows patient consent to be waived so scientists can develop desperately needed emergency treatment.

Lead investigator and trauma surgeon Ernest Moore says research in the field is the only way to prove that artificial blood can save lives. DR. ERNEST MOORE, CHIEF OF TRAUMA SURGERY, DENVER HEALTH MEDICAL CTR.: Unless we conduct research under these conditions, it'll never get done.

GUPTA: Patient advocates object, saying patients should always get their choice.

ARTHUR CAPLAN, MEDICAL ETHICIST: It's also not clear that the only way to try artificial blood is in this particular setting. You could have people volunteer, you could have restrictions only to people who are somewhat conscious or have a family member there and could give consent to this.

GUPTA: Dr. Moore says consent is already implied for IVs and breathing tubes. This should no different.

MOORE: Hopefully in patients who previously died because of blood loss we will now be able to save them.

GUPTA: The blood substitutes manufactures is handing out bracelets in the test cities to anyone who does not want it. But doctors involved in the study are hopeful a blood substitute will have broader use.

DR. MICHAEL PASQUALE, CHIEF OF DIV. OF TRAUMA, LEHIGH VALLEY HOSPITAL: The hope is that eventually you could potentially use this for any procedure where blood was required.

GUPTA: And potentially save many more lives.

Dr. Sanjay Gupta, CNN, Atlanta.

(END VIDEOTAPE)

KAGAN: You heard from the trauma surgeon, Ernest Moore, in that story. He's our guest now from Denver to talk more about this potentially life-saving blood substitute and the concerns over testing it.

Doctor Moore, good morning. Thank you for work us.

MOORE: Good morning.

KAGAN: If you could explain to us again or more specifically how this product work and why it can be, as you see it, life saving.

MOORE: Well, this product serves as actually a substitute for red cells. Their functioned to carry oxygen. So it's a temporary replacement when patients lose a massive amount of red cells.

Unfortunately, the current treatment, crystaloid, does not carry oxygen. Therefore, patients who have massive blood loss are an imminent threat for their life unless the oxygen-carrying capacity can be restored properly.

KAGAN: And so it sounds like a good thing. Why, though -- and you make this point in the piece -- but why do you believe it has to be tested in this way? Why can't it be tested in other ways?

MOORE: Well, first of all, it's important to understand it has been tested in other scenarios. At our institution, we have tested this product in patients with acute blood loss over the past 11 years. We have an experience over 150 patients. And, with the FDA, has closely scrutinized both its safety and efficacy, but it has never been tested in the scenario of the scene of the accident. That's why it's critical that this study be produced.

KAGAN: So as I understand it, in communities, as we heard in Sanjay's piece, in communities where this is being tested, you can go get a bracelet if you perhaps would be -- find yourself in an accident and you don't want this product used on you, if you have ethical or religious reasons that you wouldn't want a blood product used on you.

MOORE: That's correct.

KAGAN: And how far down the line, doctor, do you see if this product is completely approved and it works as well as you think it's going to, that this will be a normal part of treatment?

MOORE: Well, the study is planned for at least one year. But if the results are positive, this could completely revolutionize how we manage resuscitation of injured patients. We haven't made advances for over 35 years. This could represent the singular most important advance in the resuscitation of the injured patient in many of our lifetimes.

KAGAN: And you will be watching it from Denver. Dr. Ernest Moore, thanks for your time, doctor, appreciate it.

MOORE: Thank you.

KAGAN: Time for us to take a quick break. We'll be back, after this.

(COMMERCIAL BREAK)

(STOCK MARKET REPORT)

KAGAN: One more note, from the wise acres at "The David Letterman Show," whoever said that politics wasn't stimulating, even at a late hour, take a look at this.

(BEGIN VIDEO CLIP)

GEORGE W. BUSH, PRESIDENT OF THE UNTIED STATES: Need to maintain spending discipline in our nation's capital. I've had plans to protect small business owner and employees...

I actually did vote for the 87 billion...

(APPLAUSE)

... state house members, all the local officials. The high sheriff is with us today. (LAUGHTER)

... if you're worried about the quality of the education.

(LAUGHTER)

We stand for the fair treatment of faith-based groups, who will receive federal support for their work.

(LAUGHTER)

... will not happen on my watch.

(LAUGHTER)

(END VIDEO CLIP)

KAGAN: What is funnier, the kid or that everybody around him -- not a single person even reacts to those hijinks?

Had to share that giggle there.

We'll take a look at weather, coming up in just a bit.

(COMMERCIAL BREAK)

KAGAN: All right, had a good giggle before the break, that video from David Letterman. We're being told by the White House that the kid, as funny as he was, was edited into that video, which would explain why the people around him weren't really reacting. So that from the White House.

Speaking of what goes on the air, just as the FCC is cracking down on decency, syndicated shock jock Opie and Anthony reportedly will be back on the air in June. Infinity had reportedly yanked their show after an on-air stunt involving a man and woman who were supposed to be having sex in the St. Patrick's Cathedral. I remember that fun moment. Infinity didn't fire Opie and Anthony, rather they have remained under contract, drawing their paychecks. And now that contract is about to expire, paying the way for the duo's return.

All right then.

(WEATHER REPORT)

KAGAN: That's going to wrap it up for us. I'm Daryn Kagan. I will be right back here tomorrow morning.

TO ORDER A VIDEO OF THIS TRANSCRIPT, PLEASE CALL 800-CNN-NEWS OR USE OUR SECURE ONLINE ORDER FORM LOCATED AT www.fdch.com